ATE334689T1 - Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe - Google Patents

Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe

Info

Publication number
ATE334689T1
ATE334689T1 AT96939247T AT96939247T ATE334689T1 AT E334689 T1 ATE334689 T1 AT E334689T1 AT 96939247 T AT96939247 T AT 96939247T AT 96939247 T AT96939247 T AT 96939247T AT E334689 T1 ATE334689 T1 AT E334689T1
Authority
AT
Austria
Prior art keywords
medium
active ingredients
analgesic
inflammatory
pharmaceutical compositions
Prior art date
Application number
AT96939247T
Other languages
English (en)
Inventor
Petrus Johannes Meyer
Original Assignee
Univ Northwest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northwest filed Critical Univ Northwest
Application granted granted Critical
Publication of ATE334689T1 publication Critical patent/ATE334689T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT96939247T 1995-11-13 1996-11-13 Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe ATE334689T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA959609 1995-11-13

Publications (1)

Publication Number Publication Date
ATE334689T1 true ATE334689T1 (de) 2006-08-15

Family

ID=25585417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939247T ATE334689T1 (de) 1995-11-13 1996-11-13 Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe

Country Status (13)

Country Link
US (1) US6221377B1 (de)
EP (1) EP0866713B1 (de)
JP (1) JP2000500449A (de)
CN (1) CN1102852C (de)
AT (1) ATE334689T1 (de)
AU (1) AU730495B2 (de)
BR (1) BR9611523A (de)
CA (1) CA2237306C (de)
DE (1) DE69636413T2 (de)
NO (1) NO982161L (de)
NZ (1) NZ322588A (de)
PT (1) PT866713E (de)
WO (1) WO1997017978A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
DE19851604A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Injektionsanästhesiemittel mit hydrophiler Phase
DE19851605A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Mikropartikel enthaltendes Injektionsanästhesiemittel
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
WO2002005849A2 (en) * 2000-07-19 2002-01-24 Pitmy International N.V. Transportation of nucleic acid substances
AU2001283586A1 (en) * 2000-07-19 2002-01-30 Pitmy International N.V. Enhancement of the action of anti-infective agents
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
US20070112052A9 (en) * 2001-01-05 2007-05-17 Larry Caldwell Methods and compositions for treating headache pain with topical NSAID compositions
SE523017C2 (sv) * 2001-03-30 2004-03-23 Aga Ab Publ Spolfluidkomposition
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1492511B3 (de) 2002-04-09 2012-05-02 Flamel Technologies Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US7714015B2 (en) * 2003-08-07 2010-05-11 Lil Brat Pharmaceuticals Of Marlette, Mi Method and composition for treating sunburned skin
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CA2596920C (en) * 2005-01-28 2015-05-05 North-West University Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines
US7442690B2 (en) * 2005-03-14 2008-10-28 P & L Enterprise Llc Topical treatment for psoriasis
US20060281775A1 (en) 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
CA2623201A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US9023400B2 (en) * 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
US20080306132A1 (en) * 2007-06-07 2008-12-11 Praveen Hiremath Novel oral compositions of carporen
US20100297249A1 (en) 2007-07-05 2010-11-25 North-West University Enhancement of the efficacy of therapeutic proteins
US8933255B2 (en) * 2008-12-31 2015-01-13 Nitromega Corp. Nutraceuticals containing nitro fatty acids
FR2944969B1 (fr) * 2009-04-29 2011-08-26 Air Liquide Utilisation de n2o gazeux dans le traitement des douleurs chroniques
US20110037455A1 (en) * 2009-08-17 2011-02-17 Oren Navot System for measuring electrical power
ES3037313T3 (en) 2009-10-12 2025-09-30 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US20130109674A1 (en) * 2009-12-18 2013-05-02 Achelios Therapeutics Llc Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
ITMI20121316A1 (it) 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
HRP20220112T1 (hr) 2013-12-24 2022-04-15 Virginia Commonwealth University Upotreba oksidacijskog sulfata kolesterola (ocs) za liječenje akutne insuficijencije jetre
WO2016089893A1 (en) 2014-12-01 2016-06-09 Achelios Therapeutics Inc. Methods and compositions for treating migraine and conditions associated with pain
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
HK1244715A1 (zh) 2015-03-02 2018-08-17 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
WO2024162962A1 (en) * 2023-02-01 2024-08-08 Garrison Thomas E Mixtures including nitrous oxide
US11980717B1 (en) 2023-02-01 2024-05-14 Thomas E. Garrison Mixtures including nitrous oxide
US12280216B2 (en) 2023-02-01 2025-04-22 Thomas E. Garrison Mixtures including nitrous oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2132236T3 (es) * 1992-06-08 1999-08-16 Pitmy Int Nv Composicion dermatologica conteniendo oxido nitroso.
GB9308306D0 (en) * 1993-04-22 1993-06-09 Univ Aberdeen Analgesic composition

Also Published As

Publication number Publication date
PT866713E (pt) 2006-12-29
WO1997017978A1 (en) 1997-05-22
CA2237306C (en) 2008-10-07
JP2000500449A (ja) 2000-01-18
AU730495B2 (en) 2001-03-08
NO982161D0 (no) 1998-05-12
EP0866713A1 (de) 1998-09-30
CA2237306A1 (en) 1997-05-22
CN1102852C (zh) 2003-03-12
BR9611523A (pt) 1999-12-28
US6221377B1 (en) 2001-04-24
NO982161L (no) 1998-07-02
CN1205641A (zh) 1999-01-20
NZ322588A (en) 1999-01-28
EP0866713B1 (de) 2006-08-02
DE69636413T2 (de) 2007-03-29
AU7637196A (en) 1997-06-05
DE69636413D1 (de) 2006-09-14

Similar Documents

Publication Publication Date Title
ATE334689T1 (de) Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
EA200300634A1 (ru) Фармацевтическая композиция, содержащая действующее вещество, диспергированное в матрице
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
JPH0420886B2 (de)
AU2002221939A1 (en) Rapidly disintegrating tablet comprising an acid-labile active ingredient
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
ES2174814T3 (es) Acidos grasos esenciales destinados en la prevencion de accidentes cardio-vasculares.
ATE226815T1 (de) Herstellung von arzneimitteln
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
NO20014719D0 (no) Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler
MXPA03001762A (es) Proceso para preparar composiciones farmaceuticas para uso con formulaciones de gelatina suave.
ATE59291T1 (de) 2-(2-fluor-4-biphenylyl)propionsaeure oder deren salze enthaltende arzneimittel.
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
ATE329621T1 (de) Pharmazeutische injizierbare lösungen, die paracetamol und kombinationen aus paracetamol mit anderen aktivsubstanzen enthalten
IT1252692B (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
CA2137764A1 (en) Pharmaceutical compositions comprising solutions or dispersions of a staurosporine active ingredient in a saturated polyalkylene glycol glyceride
IL101710A0 (en) Transdermal formulations with increased permeation of the active substances
JPS5675423A (en) Physiologically active high polymer substance-containing composition for mucosa administration and its preparation
KR910014337A (ko) d-2-(6-메톡시-2-나프릴)-프로피온산의 광학활성 유도체와 이것을 함유한 약제학적 조성물
PE20020055A1 (es) Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
ES456094A1 (es) Un procedimiento para la preparacion de 2-acetoxi-benzoato de 2-(carbamoil) fenilo.
IT1272195B (it) Formulazione farmaceutica per uso topico a base di benzidamina e procedimento per la sua preparazione
JPS6153215A (ja) 坐剤基剤およびこれを用いる坐剤
KR900012613A (ko) 경구 투여용 의약조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0866713

Country of ref document: EP